{
    "nctId": "NCT05490433",
    "briefTitle": "Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction",
    "officialTitle": "A Prospective Multicenter Randomized Clinical Trial: Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction (ROM) Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Patients in Stage 0-3A in Preoperative Evaluation",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 790,
    "primaryOutcomeMeasure": "5-year disease-free survival rate(DFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult women over the age of 19 with breast cancer scheduled for therapeutic mastectomy and who want immediate reconstruction\n* Stage 0-III breast cancer at initial evaluations\n* ECOG performance status of 0 or 1\n\nExclusion Criteria:\n\n* Patients planned for breast-conserving surgery or who are not candidates for IBR are excluded.\n* Clinical evidence for nipple or skin involvement of tumors in preoperative evaluations\n* A pregnant or lactating woman\n* Only tumors with lobular carcinoma in situ\n* Mammary Paget's disease\n* Inflammatory breast cancer\n* Male breast cancer\n* Stage IIIB-IV disease at initial presentation\n* Women with breast Cup E or higher\n* Previous history of breast cancer (metachronous breast cancer)\n* Previous history of non-mammary malignant disease excluding non-melanoma skin cancer or thyroid papillary/follicular cancer\n* Special type cancer (phyllodes tumor, sarcoma, and lymphoma)\n* Age \\> 70\n* ASA, grade 4 or higher\n* Patients who do not have the ability to give informed consent\n* Previous thoracic radiation history\n* Patients who have not been tested for hepatitis before surgery (HBV, HCV) and HIV (compensation insurance policy)",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}